FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and chemical-pharmaceutical industry. A composition contains a corticosteroid and an antihistamine, phospholipid liposomes, a pharmaceutically acceptable aqueous carrier and a pharmaceutically acceptable buffer likely to control pH approximately 4 to 8. Herewith the antihistamine is cetirizine and its salts, and the corticosteroid is budesonide, ciclesonide, fluticasone, triamcinolone, mometasone and their salts.
EFFECT: preparing the homogenous pharmaceutical composition for treating, eg rhinitis, asthma and/or chronic obstructive pulmonary disease.
58 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD AND COMPOSITION FOR TREATMENT OF INFLAMMATORY DISORDERS | 2006 |
|
RU2468797C2 |
| BILAYER PREPARATIONS | 1995 |
|
RU2166332C2 |
| PHARMACEUTICAL COMPOSITIONS TO REDUCE COMPLICATIONS OF OCULAR STEROID | 2013 |
|
RU2660585C2 |
| LIPOSOMAL DRUG FOR USE IN THE TREATMENT OF MALIGNANT NEOPLASM | 2017 |
|
RU2756755C2 |
| DRIED RECONSTITUTED VESICLES FOR PHARMACEUTICAL APPLICATION | 2007 |
|
RU2443412C2 |
| PARENTERAL FORMULATIONS OF ELACYTARABINE DERIVATIVES | 2011 |
|
RU2571283C2 |
| METHODS TO REDUCE COMPLICATIONS FROM INTRA-ARTICULAR STEROID | 2019 |
|
RU2806023C2 |
| LIPOSOMAL COMPOSITION | 2010 |
|
RU2476216C1 |
| SKIN TREATMENT COMPOSITION CONTAINING HUMAN GROWTH HORMONES AS ACTIVE INGREDIENT | 2005 |
|
RU2401099C2 |
| COMPOSITIONS AND METHODS OF TREATING BLADDER CANCER | 2008 |
|
RU2542449C2 |
